History
  • No items yet
midpage
Ballesteros v. Galectin Therapeutics, Inc.
2016 U.S. App. LEXIS 22317
| 11th Cir. | 2016
Read the full case

Background

  • Hotz bought 16,000 shares of Galectin stock in Feb. 2014 and alleged he and a class were harmed when Galectin’s stock collapsed after reports that Galectin paid third-party promoters to tout the stock (price fell ~55% on July 28–29, 2014).
  • Galectin sold shares via two “at-the-market” (ATM) offerings (Oct. 25, 2013 and Mar. 21, 2014) to raise capital; Hotz alleges the company timed/promoted the market to raise funds at inflated prices and minimize dilution to insiders.
  • Galectin engaged four promoters (Dream Team, Patrick Cox, TDM, Acorn); some promoters disclosed payments (TDM, Acorn), others did not (Dream Team, Cox); Galectin itself did not disclose these promoter payments in SEC filings or ATM documents beyond vague consulting language.
  • Hotz sued under § 10(b)/Rule 10b‑5(b) (misrepresentation/omission) and § 20(a) (control-person liability), alleging that failing to disclose payments and representing “no manipulation” were false or misleading; no allegation that promotional articles themselves contained false factual claims.
  • The district court dismissed under Rule 12(b)(6); the Eleventh Circuit affirmed, holding (a) Galectin was not the “maker” of promoters’ statements under Janus; (b) hiring/promoting by issuer without more is not securities-market “manipulation”; (c) reporting ATM sale figures did not create a duty to disclose promoter payments; (d) absent a primary § 10(b) violation, § 20(a) claim fails.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Galectin can be liable under Rule 10b‑5(b) for statements in third‑party promotional articles Promoters were agents of Galectin because Galectin paid them, so Galectin “made” or is responsible for the promoters’ statements/omissions Under Janus, only the entity with ultimate authority over content “makes” a statement; payment alone doesn’t show control Dismissed — payment to promoters insufficient to show Galectin “made” the statements (Janus controls)
Whether Galectin’s ATM representations that it had not manipulated the stock were false/misleading because it paid promoters to tout the stock Hiring/promoters to pump price rendered the “no manipulation” statement false or misleading Securities-law “manipulation” denotes deceptive market conduct (wash sales, matched orders, rigged prices); hiring promoters and publishing truthful/boastful articles is lawful and not manipulation Dismissed — no alleged manipulative market activity; the “no manipulation” statement was not untrue as a matter of law
Whether omission of disclosure about promoter payments in 10‑K/10‑Q and ATM notices was a fraudulent omission under Rule 10b‑5(b) By disclosing ATM sale figures, Galectin created a duty to disclose other facts (promoter payments) necessary to avoid misleading investors Duty to disclose promoter payments lies with promoters under § 17(b); truthful reporting of sale figures did not render those figures misleading or create a duty to disclose payments Dismissed — no duty to disclose payments; reporting of ATM figures did not make statements misleading
Whether § 20(a) control‑person claims survive absent a primary § 10(b) violation Officers, directors, and 10X Fund controlled Galectin and so are secondarily liable Control‑person liability is secondary and requires an underlying primary violation Dismissed — no primary § 10(b) violation alleged, so § 20(a) claim fails

Key Cases Cited

  • Janus Capital Grp. v. First Derivative Traders, 564 U.S. 135 (2011) (defendant liable under Rule 10b‑5(b) only if it is the person with ultimate authority who "made" the statement)
  • Halliburton Co. v. Erica P. John Fund, 134 S. Ct. 2398 (2014) (elements of Rule 10b‑5 claim and reliance/loss‑causation principles)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility pleading standard under Rule 8)
  • Basic Inc. v. Levinson, 485 U.S. 224 (1988) (silence not misleading absent duty to disclose; partial disclosures can create duty)
  • Santa Fe Indus., Inc. v. Green, 430 U.S. 462 (1977) (definition of market manipulation and requirement of deceptive market activity)
  • Ernst & Ernst v. Hochfelder, 425 U.S. 185 (1976) (scienter requirement and definition of manipulation as intentional deceptive conduct)
  • Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27 (2011) (omissions can be material under Rule 10b‑5(b))
  • FindWhat Investor Grp. v. FindWhat.com, 658 F.3d 1282 (11th Cir.) (disclosure of one fact may give rise to duty to speak fully; guidance on omissions)
Read the full case

Case Details

Case Name: Ballesteros v. Galectin Therapeutics, Inc.
Court Name: Court of Appeals for the Eleventh Circuit
Date Published: Dec 15, 2016
Citation: 2016 U.S. App. LEXIS 22317
Docket Number: 16-10324
Court Abbreviation: 11th Cir.